Login| Sign Up| Help| Contact|

Patent Searching and Data

Document Type and Number:
WIPO Patent Application WO/2019/137922
Kind Code:
The present invention relates to modulators of complex 1 protein q (C1q) that preferably mimic and/or stabilize the interaction of inhibitor apolipoprotein-E (ApoE) with C1q, and their uses in the prevention or treatment of C1q-related diseases or conditions, such Alzheimer's disease (AD), atherosclerosis, kidney diseases, and ageing.

SKERKA, Christine (Schillbachstraße 34, Jena, 07743, DE)
ZIPFEL, Peter (Schillbachstraße 34, Jena, 07743, DE)
ACKERMANN, Susanne (Zeppelinplatz 5, Weimar, 99423, DE)
Application Number:
Publication Date:
July 18, 2019
Filing Date:
January 08, 2019
Export Citation:
Click for automatic bibliography generation   Help
International Classes:
A61P25/28; A61P9/00; A61P13/12; A61P21/00; C07K14/435; G01N33/50
Domestic Patent References:
Foreign References:
Other References:
ROUMENINA L. ET AL.: "Complement Clq-target proteins recognition is inhibited by electric moment effectors", J MOL RECOGNIT, vol. 20, no. 5, September 2007 (2007-09-01), pages 405 - 15
ROOS, A. ET AL.: "Specific Inhibition of the Classical Complement Pathway by Clq-Binding Peptides", J IMMUNOL, vol. 167, no. 12, 15 December 2001 (2001-12-15), pages 7052 - 7059, XP001056046
THIELENS N.M. ET AL.: "Clq: A fresh look upon an old molecule", MOL IMMUNOL, vol. 89, September 2017 (2017-09-01), pages 73 - 83, XP085162865, DOI: doi:10.1016/j.molimm.2017.05.025
HAJISHENGALLIS G ET AL.: "Novel mechanisms and functions of complement", NAT IMMUNOL, vol. 18, no. 12, 16 November 2017 (2017-11-16), pages 1288 - 1298
HASKARD DO ET AL.: "The role of complement in atherosclerosis", CURR OPIN LIPIDOL, vol. 19, no. 5, October 2008 (2008-10-01), pages 478 - 82
LIU ET AL.: "Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice", ATHEROSCLEROSIS, vol. 234, no. l, May 2014 (2014-05-01), pages 237 - 43
YONG SHEN: "What does complement do in Alzheimer's disease? Old molecules with new insights", TRANSL NEURODEGENER, vol. 2, 2013, pages 21, XP021165528, DOI: doi:10.1186/2047-9158-2-21
SPEIDL WS ET AL.: "Complement in atherosclerosis: friend or foe?", J THROMB HAEMOST, vol. 9, no. 3, March 2011 (2011-03-01), pages 428 - 40
ANDREI SA ET AL.: "Stabilization of protein-protein interactions in drug discovery", EXPERT OPIN DRUG DISCOV, vol. 12, no. 9, September 2017 (2017-09-01), pages 925 - 940
WILES MV ET AL.: "CRISPR-Cas9-mediated genome editing and guide RNA design", MAMM GENOME, vol. 26, no. 9-10, October 2015 (2015-10-01), pages 501 - 10
SAVIC N; SCHWANK G: "Advances in therapeutic CRISPR/Cas9 genome editing", TRANSL RES, vol. 168, February 2016 (2016-02-01), pages 15 - 21, XP029385959, DOI: doi:10.1016/j.trsl.2015.09.008
GABORIAUD C. ET AL.: "The crystal structure of the globular head of complement protein Clq provides a basis for its versatile recognition properties", J BIOL CHEM., vol. 278, no. 47, 2003, pages 46974 - 82, XP002597310, DOI: doi:10.1074/JBC.M307764200
MAJOR ET AL.: "Calcium-dependent conformational flexibility of a CUB domain controls activation of the complement serine protease Clr", J BIOL CHEM., vol. 285, no. 16, 2010, pages 11863 - 9
ALMITAIRI JOM ET AL.: "Structure of the C1r-C1s interaction of the C1 complex of complement activation", PROC NATL ACAD SCI USA., vol. 115, no. 4, 2018, pages 768 - 773
ALMITAIRI JOM ET AL.: "Structure of the Clr-Cls interaction of the C1 complex of complement activation", PROC NATL ACAD SCI USA, vol. 115, no. 4, 2018, pages 768 - 773
BELL, R. D. ET AL.: "Apolipoprotein E controls cerebrovascular integrity via cyclophilin A", NATURE, vol. 485, 2012, pages 512 - 516
HOFMAN, A. ET AL.: "Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study", LANCET, vol. 349, 1997, pages 151 - 154, XP005061658, DOI: doi:10.1016/S0140-6736(96)09328-2
HOLTZMAN, D. M.; HERZ, J.; BU, G.: "Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease", COLD SPRING HARB PERSPECT MED, vol. 2, 2012, pages a006312
KANEKIYO, T.; XU, H.; BU, G.: "ApoE and Ap in Alzheimer's Disease: Accidental Encounters or Partners?", NEURON, vol. 81, 2014, pages 740 - 754, XP028616093, DOI: doi:10.1016/j.neuron.2014.01.045
MAHLEY, R. W.; HUANG, Y.: "Apolipoprotein e sets the stage: response to injury triggers neuropathology", NEURON, vol. 76, 2012, pages 871 - 885, XP028960119, DOI: doi:10.1016/j.neuron.2012.11.020
ZLOKOVIC, B. V.: "Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease", JAMA NEUROL, vol. 70, 2013, pages 440 - 444
SHUVAEV, V. V.; LAFFONT, I.; SIEST, G.: "Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix", FEBS LETT, vol. 459, 1999, pages 353 - 357, XP004375859, DOI: doi:10.1016/S0014-5793(99)01285-5
WITZTUM, J. L.; LICHTMAN, A. H.: "The influence of innate and adaptive immune responses on atherosclerosis", ANNU REV PATHOL, vol. 9, 2014, pages 73 - 102
HANSSON, G. K.; HERMANSSON, A.: "The immune system in atherosclerosis", NAT IMMUNOL, vol. 12, 2011, pages 204 - 212
WEBER, C.; NOELS, H.: "Atherosclerosis: current pathogenesis and therapeutic options", NAT MED, vol. 17, 2011, pages 1410 - 1422
LIBBY, P.; RIDKER, P. M.; HANSSON, G. K.: "Progress and challenges in translating the biology of atherosclerosis", NATURE, vol. 473, 2011, pages 317 - 325
GOLDMANN, T. ET AL.: "Origin, fate and dynamics of macrophages at central nervous system interfaces", NAT IMMUNOL, vol. 17, 2016, pages 797 - 805
LUN, M. P.; MONUKI, E. S.; LEHTINEN, M. K.: "Development and functions of the choroid plexus-cerebrospinal fluid system", NAT REV NEUROSCI, vol. 16, 2015, pages 445 - 457
MOORE, G. R. ET AL.: "Complement and Humoral Adaptive Immunity in the Human Choroid Plexus: Roles for Stromal Concretions, Basement Membranes, and Epithelium", J NEUROPATHOL EXP NEUROL, vol. 75, 2016, pages 415 - 428
RANSOHOFF, R. M.; ENGELHARDT, B.: "The anatomical and cellular basis of immune surveillance in the central nervous system", NAT REV IMMUNOL, vol. 12, 2012, pages 623 - 635
SCHWARTZ, M.; BARUCH, K.: "The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus", EMBO J., vol. 33, 2014, pages 7 - 22
SHECHTER, R.; LONDON, A.; SCHWARTZ, M.: "Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates", NAT REV IMMUNOL, vol. 13, 2013, pages 206 - 218
BINDER, C. J.; PAPAC-MILICEVIC, N.; WITZTUM, J. L.: "Innate sensing of oxidation-specific epitopes in health and disease", NAT REV IMMUNOL, vol. 16, 2016, pages 485 - 497
WEISMANN, D. ET AL.: "Complement factor H binds malondialdehyde epitopes and protects from oxidative stress", NATURE, vol. 478, 2011, pages 76 - 81, XP055044028, DOI: doi:10.1038/nature10449
ZIPFEL, P. F.; SKERKA, C.: "Complement regulators and inhibitory proteins", NAT REV IMMUNOL, vol. 9, 2009, pages 729 - 740
ARLAUD, G. J.; BIRO, A.; LING, W. L.: "Enzymatically Modified Low-Density Lipoprotein Is Recognized by Clq and Activates the Classical Complement Pathway", JOURNAL OF LIPIDS, vol. 2011, 2011, pages 376092
WILSON, C. ET AL.: "Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E", SCIENCE, vol. 252, 1991, pages 1817 - 1822
VENKATRAMAN GIRIJA, U. ET AL.: "Structural basis of the Clq/Cls interaction and its central role in assembly of the C1 complex of complement activation", PROC NATL ACAD SCI USA, vol. 110, 2013, pages 13916 - 13920
BRAAK, H. ET AL.: "Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry", ACTA NEUROPATHOL, vol. 112, 2006, pages 389 - 404, XP019442875, DOI: doi:10.1007/s00401-006-0127-z
THAI, D. R.; RUB, U.; ORANTES, M.; BRAAK, H.: "Phases of Ap-deposition in the human brain and its relevance for the development of AD", NEUROLOGY, vol. 58, 2002, pages 1791 - 1800
STARY, H. C.: "Natural history and histological classification of atherosclerotic lesions: an update", ARTERIOSCLER THROMB VASC BIOL, vol. 20, 2000, pages 1177 - 1178
ZHANG, B. ET AL.: "Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease", CELL, vol. 153, 2013, pages 707 - 720, XP028589810, DOI: doi:10.1016/j.cell.2013.03.030
HOVLAND, A. ET AL.: "The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis", ATHEROSCLEROSIS, vol. 241, 2015, pages 480 - 494
CRAMER, P. E. ET AL.: "ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models", SCIENCE, vol. 335, 2012, pages 1503 - 1506, XP055159821, DOI: doi:10.1126/science.1217697
DINARELLO, C. A.: "Anti-inflammatory Agents: Present and Future", CELL, vol. 140, 2010, pages 935 - 950
GLASS, C. K. ET AL.: "Mechanisms Underlying Inflammation in Neurodegeneration", CELL, vol. 140, 2010, pages 918 - 934, XP055280584, DOI: doi:10.1016/j.cell.2010.02.016
HESS, C.; KEMPER, C.: "Complement-Mediated Regulation of Metabolism and Basic Cellular Processes", IMMUNITY, vol. 45, 2016, pages 240 - 254, XP029687772, DOI: doi:10.1016/j.immuni.2016.08.003
TABAS, I.; GLASS, C. K.: "Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities", SCIENCE, vol. 339, 2013, pages 166 - 172
ZIPFEL, P. F.; C. SKERKA: "Complement regulators and inhibitory proteins", NAT REV IMMUNOL, vol. 9, 2009, pages 729 - 740
SARMA, J. V.; P. A. WARD: "The complement system", CELL TISSUE RES, vol. 343, 2011, pages 227 - 235, XP019870471, DOI: doi:10.1007/s00441-010-1034-0
MATHERN, D. R.; P. S. HEEGER: "Molecules Great and Small: Complement System", CLIN JAM SOC NEPHROL, 2015
RICKLIN D.; HAJISHENGALLIS G.; YANG K.; LAMBRIS J.D.: "The Complement - a key system for immune surveillance and homeostasis", NAT IMMUNOL, vol. 11, no. 9, 2010, pages 785 - 797, XP055306904, DOI: doi:10.1038/ni.1923
FLEMING S.D.: "Naturally occuring autoantibodies mediate ischemia/reperfusion-induced tissue injury", ADV. EXP. MED. BIOL., 2012, pages 750174 - 85
MILLER, CHOI S.H.; WIESNER P.; FANG L.; HARKEWICZ R; HARTVIGSEN K.; BOULLIER A.; GONEN A.; DIEHL C.J.; QUE X.; MONTANO E.: "Oxidation-Specific Epitopes are Danger Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate", IMMUNITY CIRC RES, vol. 108, no. 2, 2011, pages 235 - 248
GRONWALL C; SILVERMAN GJ: "Natural IgM: Beneficial autoantibodies for the control of inflammatory and autoimmune disease", J CLIN. IMMUNOL., vol. 34, no. 1512-21, 2014
PANDA S; DING JL: "Natural antibodies bridge innate and adaptive immunity", J CLIN. IMMUNOL., vol. 194, 2015, pages 13 - 20, XP055456790, DOI: doi:10.4049/jimmunol.1400844
Attorney, Agent or Firm:
BOEHMERT & BOEHMERT (Krauss, JanPettenkoferstraße 20-22, München, 80336, DE)
Download PDF: